News
RAUMEDIC and Sartorius Stedim Biotech Sign Partnership Agreement
Sartorius Stedim Biotech (SSB), an international leading pharma and biotech supplier, and RAUMEDIC, a leading worldwide OEM manufacturer of medical- and pharmaceutical-grade polymer components...
Press Releases
Cytheris and CITN announce selection of recombinant interleukin-7 (CYT107) for initial studies at member institutions
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, and the Cancer Immunotherapy Trials Network...
Press Releases
Roche and Merck Establish Strategic Agreements in Fight Against Chronic Hepatitis C
Roche announced that it has entered into agreements with Merck, known as MSD outside the United States, through their respective subsidiaries, to improve the...
Techno Trends
Omega-3 Fatty Acids Help Heart Patients With Stents
Combining omega-3 fatty acids with blood-thinning drugs may reduce the risk of heart attacks in patients who've had stents placed in their coronary arteries,...
News
Clinical phase III studies of Lu AA21004 presented for the first time at the 2011 Annual Meeting
H. Lundbeck A/S announced the presentation of new data from the clinical phase III program of Lu AA21004, an investigational compound for the treatment...
Clinical Trials
First ever study to apply therapeutic approach of global immune reconstitution to treatment of cancer patients
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard (Lyon), the...
Articles
Can pharma truly embrace social media?
It seems every industry is jumping on the social media bandwagon. But how can social media prove beneficial to the tightly regulated world...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read